Bausch Health Companies Inc. (NYSE:BHC) Q4 2024 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE:BHC) Q4 2024 Earnings Call Transcript February 19, 2025Bausch Health Companies Inc. misses on earnings expectations.
Bausch Health Companies Inc. (BHC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Icahn Capital LP Carl Icahn | 34,721,118 | $279,852,211 | 3.77% | |
| 2. | GoldenTree Asset Management Steven Tananbaum | 27,540,075 | $221,749,352 | -7% | 17.03% |
| 3. | Paulson & Co John Paulson | 26,439,035 | $213,098,622 | 12.89% | |
| 4. | MFN Partners Farhad Nanji And Michael Demichele | 6,000,000 | $48,360,000 | 0.95% | |
| 5. | Maple Rock Capital Len Kipp And Xavier Majic | 5,300,000 | $42,718,000 | +157% | 1.28% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.17 | 10,000 | Director | 10,000 | 2021-11-30 | Filing | |
| $24.24 | 50,000 | Director | 60,780 | 2021-11-30 | Filing | |
| $25.94 | 1,400 | Director | 38,647 | 2021-08-05 | Filing | |
| $25.01 | 10,000 | Director | 317,109 | 2021-08-04 | Filing | |
| $19.24 | 948,353 | Director, Other | 17,931,594 | 2020-06-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.35 | 440 | Officer | 433,066 | 2024-12-02 | Filing | |
| $6.21 | 13,370 | Officer | 435,198 | 2024-09-06 | Filing | |
| $9.80 | 133 | Officer | 499,905 | 2024-03-04 | Filing | |
| $9.80 | 1,561 | Officer | 500,038 | 2024-03-04 | Filing | |
| $9.80 | 199 | Officer | 501,599 | 2024-03-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,416,939 | $124,257,857 | 0.13% | |
| 2. | 13,000,000 | $104,780,000 | 0.22% | |
| 3. | 11,684,859 | $94,460,400 | 0% | |
| 4. | 11,345,000 | $91,440,700 | 0.12% | |
| 5. | 11,188,348 | $90,178,000 | 0.01% |
News See All
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
Billionaire Paul Singer's Top 12 Long-Term Stock Picks
The world's "most feared investor," Paul Singer, needs no introduction.
11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now
In the face of economic uncertainty, consumer preferences in the beauty industry are changing.
10 Best Canadian Stocks to Buy Under $10
The Canadian stock market had a positive third quarter, following a sluggish start earlier in 2024. The market was driven by domestic rate cuts and rebounding global markets.
Bausch Health Companies Inc. (NYSE:BHC) Q3 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the Bausch Health Third Quarter 2024 Earnings Call. [Operator Instructions]. Please note this conference is being recorded.
Carl Icahn Stock Portfolio: 7 Best Stocks to Buy
Carl Icahn is a force to reckon with, having made a name and billions of dollars on questioning decisions and strategies of corporate leaders on Wall Street for decades.
Billionaire Carl Icahn's Top 10 Stocks
One would expect legendary investor Carl Icahn to go slow and cherish his extraordinary and successful career on Wall Street.
Bausch Health Companies Inc. (NYSE:BHC) Q2 2024 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE:BHC) Q2 2024 Earnings Call Transcript August 1, 2024Bausch Health Companies Inc. misses on earnings expectations.
Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.75. Bausch Health Companies Inc.
Billionaire Hedge Funds
